George Philips

1.3k total citations
41 papers, 916 citations indexed

About

George Philips is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, George Philips has authored 41 papers receiving a total of 916 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Pulmonary and Respiratory Medicine, 14 papers in Surgery and 14 papers in Oncology. Recurrent topics in George Philips's work include Bladder and Urothelial Cancer Treatments (9 papers), Prostate Cancer Treatment and Research (9 papers) and Prostate Cancer Diagnosis and Treatment (8 papers). George Philips is often cited by papers focused on Bladder and Urothelial Cancer Treatments (9 papers), Prostate Cancer Treatment and Research (9 papers) and Prostate Cancer Diagnosis and Treatment (8 papers). George Philips collaborates with scholars based in United States, Denmark and United Kingdom. George Philips's co-authors include Michael B. Atkins, Susan Halabi, Eric J. Small, Dean F. Bajorin, Ben L. Sanford, Thomas D. Trainer, Barbara Beatty, Peter Callas, Vijayalakshmi Padmanabhan and HA Drabkin and has published in prestigious journals such as Journal of Clinical Oncology, Blood and JNCI Journal of the National Cancer Institute.

In The Last Decade

George Philips

35 papers receiving 899 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
George Philips United States 15 386 311 301 254 150 41 916
Steve Nicholson United Kingdom 16 330 0.9× 257 0.8× 361 1.2× 132 0.5× 184 1.2× 34 994
Steve Gyorffy Canada 14 258 0.7× 146 0.5× 242 0.8× 220 0.9× 195 1.3× 18 798
Yaewon Yang South Korea 13 380 1.0× 115 0.4× 258 0.9× 141 0.6× 147 1.0× 54 688
Dai Ikebe Japan 15 295 0.8× 136 0.4× 252 0.8× 259 1.0× 309 2.1× 26 912
Akihira Mukaiyama Japan 8 500 1.3× 148 0.5× 196 0.7× 421 1.7× 63 0.4× 10 892
Arash Rezazadeh Kalebasty United States 14 630 1.6× 442 1.4× 364 1.2× 531 2.1× 102 0.7× 69 1.2k
Bin Meng China 18 334 0.9× 152 0.5× 245 0.8× 186 0.7× 136 0.9× 62 814
Pia Klausen Denmark 16 387 1.0× 247 0.8× 246 0.8× 118 0.5× 291 1.9× 33 928
Martin D. Phillips United States 12 349 0.9× 150 0.5× 153 0.5× 275 1.1× 144 1.0× 16 978
T. Geldart United Kingdom 15 293 0.8× 211 0.7× 202 0.7× 178 0.7× 122 0.8× 40 642

Countries citing papers authored by George Philips

Since Specialization
Citations

This map shows the geographic impact of George Philips's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by George Philips with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites George Philips more than expected).

Fields of papers citing papers by George Philips

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by George Philips. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by George Philips. The network helps show where George Philips may publish in the future.

Co-authorship network of co-authors of George Philips

This figure shows the co-authorship network connecting the top 25 collaborators of George Philips. A scholar is included among the top collaborators of George Philips based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with George Philips. George Philips is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Taber, Ann, Frederik Prip, Jerry Xiao, et al.. (2021). STAG2 as a prognostic biomarker in low-grade non-muscle invasive bladder cancer. Urologic Oncology Seminars and Original Investigations. 39(7). 438.e1–438.e9. 12 indexed citations
3.
Mondal, Abdul M., Ai-Hong Ma, Guangzhao Li, et al.. (2019). Fidelity of a PDX-CR model for bladder cancer. Biochemical and Biophysical Research Communications. 517(1). 49–56. 16 indexed citations
4.
Prip, Frederik, Brent T. Harris, David A. Solomon, et al.. (2018). STAG2 Is a Biomarker for Prediction of Recurrence and Progression in Papillary Non–Muscle-Invasive Bladder Cancer. Clinical Cancer Research. 24(17). 4145–4153. 24 indexed citations
5.
Loffredo, Christopher A., et al.. (2018). Urinary Bladder Cancer in Egypt: Are There Gender Differences in Its Histopathological Presentation?. Advances in Urology. 2018. 1–7. 14 indexed citations
6.
Philips, George, et al.. (2017). Intrapancreatic Enteric Duplication Cyst Masquerading as Groove Pancreatitis. ACG Case Reports Journal. 4(1). e123–e123. 3 indexed citations
7.
Davis, Kimberly M., Charlotte J. Hagerman, Richard M. Hoffman, et al.. (2017). Physicians' Perceptions of Factors Influencing the Treatment Decision-making Process for Men With Low-risk Prostate Cancer. Urology. 107. 86–95. 10 indexed citations
8.
Atkins, Michael B. & George Philips. (2016). Emerging monoclonal antibodies for the treatment of renal cell carcinoma (RCC). Expert Opinion on Emerging Drugs. 21(3). 243–254. 5 indexed citations
9.
Cornish, Chad, et al.. (2015). Disseminated varicella-zoster virus involving the esophagus and stomach. Gastrointestinal Endoscopy. 81(5). 1282–1283. 2 indexed citations
10.
Apolo, Andrea B., Irina Ostrovnaya, Susan Halabi, et al.. (2013). Prognostic Model for Predicting Survival of Patients With Metastatic Urothelial Cancer Treated With Cisplatin-Based Chemotherapy. JNCI Journal of the National Cancer Institute. 105(7). 499–503. 68 indexed citations
11.
Monk, J. Paul, Susan Halabi, Joel Picus, et al.. (2011). Efficacy of peripheral androgen blockade in prostate cancer patients with biochemical failure after definitive local therapy. Cancer. 118(17). 4139–4147. 16 indexed citations
12.
Philips, George, Susan Halabi, Ben L. Sanford, Dean F. Bajorin, & Eric J. Small. (2009). A phase II trial of cisplatin (C), gemcitabine (G) and gefitinib for advanced urothelial tract carcinoma: results of Cancer and Leukemia Group B (CALGB) 90102. Annals of Oncology. 20(6). 1074–1079. 90 indexed citations
13.
D’Amico, Anthony V., Susan Halabi, Clare M. Tempany, et al.. (2007). Tumor Volume Changes on 1.5 Tesla Endorectal MRI During Neoadjuvant Androgen Suppression Therapy for Higher-Risk Prostate Cancer and Recurrence in Men Treated Using Radiation Therapy Results of the Phase II CALGB 9682 Study. International Journal of Radiation Oncology*Biology*Physics. 71(1). 9–15. 10 indexed citations
14.
15.
Picus, Joel, Susan Halabi, Eric J. Small, et al.. (2006). Long term efficacy of peripheral androgen blockade on prostate cancer: CALGB 9782. Journal of Clinical Oncology. 24(18_suppl). 4573–4573. 1 indexed citations
16.
Philips, George, et al.. (2005). Attitudes and Beliefs of Primary Care Physicians Regarding Prostate and Colorectal Cancer Screening in a Rural State. Journal of Cancer Education. 20(3). 167–172. 12 indexed citations
17.
Eneman, J.D. & George Philips. (2005). Cancer management in patients with end-stage renal disease.. PubMed. 19(9). 1199–212; discussion 1212. 13 indexed citations
18.
Padmanabhan, Vijayalakshmi, Peter Callas, George Philips, Thomas D. Trainer, & Barbara Beatty. (2004). DNA replication regulation protein Mcm7 as a marker of proliferation in prostate cancer. Journal of Clinical Pathology. 57(10). 1057–1062. 87 indexed citations
19.
Paskulin, Giorgio Adriano, George Philips, Rodman Morgan, et al.. (1998). Pre-clinical evaluation of probes to detect t(8;21) AML minimal residual disease by fluorescence in situ hybridization. Genes Chromosomes and Cancer. 21(2). 144–151. 15 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Steve Nicholson Breakdown of academic impact, for papers by Steve Gyorffy Breakdown of academic impact, for papers by Yaewon Yang Breakdown of academic impact, for papers by Dai Ikebe Breakdown of academic impact, for papers by Akihira Mukaiyama Breakdown of academic impact, for papers by Arash Rezazadeh Kalebasty Breakdown of academic impact, for papers by Bin Meng Breakdown of academic impact, for papers by Pia Klausen Breakdown of academic impact, for papers by Martin D. Phillips Breakdown of academic impact, for papers by T. Geldart
Rankless by CCL
2026